BWM
MEDP icon

BAM Wealth Management’s Medpace MEDP Stock Holding History

BAM Wealth Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-476
Closed -$267K – 175
2025
Q4 		$267K Sell
476
-47
-9% -$26.7K 0.19% 123
2025
Q3 		$269K Buy
+523
New +$228K 0.21% 117

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BAM Wealth Management's MEDP Position: Q1 2026 in Review

BAM Wealth Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 476 shares — an estimated $267K sold.

BAM Wealth Management first reported a position in MEDP in Q3 2025 and held it in 2 quarters. The position peaked at $269K in Q3 2025. 730 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • BAM Wealth Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • BAM Wealth Management sold 476 Medpace shares in Q1 2026, an estimated $267K.
  • BAM Wealth Management first reported a position in Medpace in Q3 2025 and held it in 2 quarters.
  • BAM Wealth Management's Medpace position peaked at $269K in Q3 2025.
  • 730 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on BAM Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.